Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_assertion type Assertion NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_head.
- NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_assertion description "[The percentages of MUC2-positive immunostaining for cystadenomas, borderline tumors, and cystadenocarcinomas were 0% (0/12), 50% (5/10), and 70% (7/10) respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_provenance.
- NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_assertion evidence source_evidence_literature NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_provenance.
- NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_assertion SIO_000772 10872659 NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_provenance.
- NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_assertion wasDerivedFrom befree-20150227 NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_provenance.
- NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_assertion wasGeneratedBy ECO_0000203 NP578845.RAjF3ANbIkh0YF6egAfWfx-_LLTL1wPM-uN7jdOuQ4ENU130_provenance.